-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Zhitong Finance App, Qingcheng New Pharmaceutical-B (02396.HK) issued an announcement. On August 14, 2026, the board of directors decided to approve the proposed adoption of the share award plan, subject to shareholders' approval. The share award scheme constitutes a share plan under Chapter 17 of the Listing Rules and will therefore comply with the provisions of Chapter 17 of the Listing Rules. On August 14, 2026, the Board of Directors decided to award the first conditional award of rewards to an employee and an advisor under the share award scheme.

Zhitongcaijing·08/14/2026 13:25:10
Listen to the news
According to Zhitong Finance App, Qingcheng New Pharmaceutical-B (02396.HK) issued an announcement. On August 14, 2026, the board of directors decided to approve the proposed adoption of the share award plan, subject to shareholders' approval. The share award scheme constitutes a share plan under Chapter 17 of the Listing Rules and will therefore comply with the provisions of Chapter 17 of the Listing Rules. On August 14, 2026, the Board of Directors decided to award the first conditional award of rewards to an employee and an advisor under the share award scheme.